287 related articles for article (PubMed ID: 26792414)
1. [What's New in Dermatological Therapy?].
Bachelez H
Ann Dermatol Venereol; 2015 Dec; 142 Suppl 3():S49-54. PubMed ID: 26792414
[TBL] [Abstract][Full Text] [Related]
2. [What's new in dermatological treatment?].
Viguier M
Ann Dermatol Venereol; 2017 Dec; 144 Suppl 4():IVS47-IVS53. PubMed ID: 29249252
[TBL] [Abstract][Full Text] [Related]
3. [What's new in dermatological therapy?].
Ezzedine K
Ann Dermatol Venereol; 2016 Dec; 143 Suppl 3():S37-S42. PubMed ID: 29429508
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
Patsatsi A; Kyriakou A
Clin Dermatol; 2021; 39(1):52-55. PubMed ID: 33972053
[TBL] [Abstract][Full Text] [Related]
5. Biologics for chronic inflammatory skin diseases: an update for the clinician.
Yao Y; Ravn Jørgensen AH; Thomsen SF
J Dermatolog Treat; 2020 Mar; 31(2):108-130. PubMed ID: 30827126
[TBL] [Abstract][Full Text] [Related]
6. Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.
Aguwa C; Enwereji N; Santiago S; Hine A; Kels GG; McGee J; Lu J
Clin Dermatol; 2023; 41(5):640-649. PubMed ID: 37816413
[TBL] [Abstract][Full Text] [Related]
7. [What’s news in dermatological therapy?].
Guillot B
Ann Dermatol Venereol; 2013 Nov; 140 Suppl 3():S293-302. PubMed ID: 24365501
[TBL] [Abstract][Full Text] [Related]
8. Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.
Yim RM; Singh I; Armstrong AW
Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147660
[TBL] [Abstract][Full Text] [Related]
9. Immunobiologicals in dermatology.
Silva DLFD; Secamilli EN; Beleli MV; Massuda JY; Franca AFEC; Magalhães RF
An Bras Dermatol; 2022; 97(3):275-283. PubMed ID: 35314083
[TBL] [Abstract][Full Text] [Related]
10. A Practical Guide to Using Biologics in Pediatric Dermatology.
George A; Lansang RP; Lansang P; Gooderham M
J Cutan Med Surg; 2024; 28(1):59-67. PubMed ID: 38229411
[TBL] [Abstract][Full Text] [Related]
11. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Analysis of Hidradenitis Suppurativa: A Unique Molecular Signature with Broad Immune Activation.
Ben Abdallah H; Bregnhøj A; Iversen L; Johansen C
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069342
[TBL] [Abstract][Full Text] [Related]
13. Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.
Tampouratzi E; Kanni T; Katsantonis J; Douvali T
F1000Res; 2019; 8():2002. PubMed ID: 33456757
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs.
Burzi L; Repetto F; Ribero S; Mastorino L; Quaglino P; Dapavo P
Dermatol Ther; 2022 Dec; 35(12):e15866. PubMed ID: 36175129
[TBL] [Abstract][Full Text] [Related]
15. Severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab.
Cho MK; Shin JU; Kim DH; Lee HJ
Clin Exp Dermatol; 2022 Dec; 47(12):2303-2305. PubMed ID: 36006169
[TBL] [Abstract][Full Text] [Related]
16. Navigating Targeted Therapeutics in Dermatology: Biologics and Small Molecules.
Costello C; Maarouf M; Shi V
J Drugs Dermatol; 2018 Dec; 17(12):1330-1332. PubMed ID: 30586268
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hidradenitis suppurativa with biologic medications.
Lee RA; Eisen DB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
[TBL] [Abstract][Full Text] [Related]
18. A case of Atopic dermatitis and Hidradenitis Suppurativa successfully treated with Dupilumab.
Gambardella A; Calabrese G; Di Brizzi EV; Alfano R; Argenziano G
J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):e284-e286. PubMed ID: 32034813
[No Abstract] [Full Text] [Related]
19. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
Kaufman BP; Alexis AF
Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
[TBL] [Abstract][Full Text] [Related]
20. Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa.
Molinelli E; Sapigni C; Simonetti O; Radi G; Gambini D; Maurizi A; Rizzetto G; D'Agostino GM; Offidani A
Dermatol Ther; 2022 Aug; 35(8):e15645. PubMed ID: 35716015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
